29.7 C
New York
Thursday, June 4, 2026

Tag: reconstruction

newssourceFORcompanyinformationcontent1marketreleases

In HelloNation, Insurance Expert Craig Willoughby of Buffalo, NY, Discusses What’s Included in Homeowners Insurance Policies

BUFFALO, N.Y., June 3, 2026 /PRNewswire/ -- What does homeowners insurance really protect, and how can homeowners avoid costly surprises? That question is answered...

IMMERSIVE XR EXPERIENCE EXPANDS THE REACH OF HOLOCAUST EDUCATION

The Claims Conference Releases A Cutting-Edge Mixed-Reality Experience Detailing The Heartbreaking And Inspiring Story Of Benno Kern, From Anschluss To Auschwitz To Liberation In Buchenwald.NEW...

U.S. Oral Surgery Management Moves into 31st State

U.S. Oral Surgery Management has four new partner practices, including its first in the state of Nebraska.

Top Los Angeles Oral and Maxillofacial Surgeon Dr. David Salehani Enhances Genioplasty and Corrective Jaw Surgery with Virtual Surgical Planning

Dr. David Salehani, a top Los Angeles oral and maxillofacial surgeon, is revolutionizing chin and jaw surgeries using Virtual Surgical Planning (VSP), a 3D planning...

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., Aug. 08, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grants of restricted stock units covering 10,200 shares of its common stock to fourteen newly-hired employees, with a grant date of August 5, 2025 (the "Grant Date"). The restricted stock units were granted pursuant to the Nasdaq Rule 5635(c)(4) inducement grant exception as a component of each individual's employment compensation and were granted as an inducement material to his or her acceptance of employment with TELA Bio.

SIGGRAPH 2025 Ignites Global AI Dialogue Across Art, Science, and Industry

Conference Unites Diverse Disciplines to Explore the Expanding Role of Artificial Intelligence in Creativity, Computation, and Connection. VANCOUVER, BC, Aug. 6, 2025 /PRNewswire/ -- From...

Blue Sky Expands the Principal Target at the Corcovo Uranium Project, Argentina

TSX Venture Exchange: BSKFrankfurt Stock Exchange: MAL2OTCQB Venture Market (OTC): BKUCF VANCOUVER, BC, Aug. 6, 2025 /CNW/ - Blue Sky Uranium Corp. (TSXV: BSK) (FSE: MAL2) (OTC:...

Blue Sky Expands the Principal Target at the Corcovo Uranium Project, Argentina

TSX Venture Exchange: BSKFrankfurt Stock Exchange: MAL2OTCQB Venture Market (OTC): BKUCF VANCOUVER, BC, Aug. 6, 2025 /PRNewswire/ - Blue Sky Uranium Corp. (TSXV: BSK) (FSE: MAL2) (OTC:...

World Intelligent Vehicle Conference 2025 Successfully Concludes

Writing a New Chapter for the Development of Intelligent Vehicles CHONGQING, China, Aug. 5, 2025 /PRNewswire/ -- World Intelligent Vehicle Conference (WIV) 2025 successfully...

Tensive appoints medical device veteran Bill Hunter Chairman as its bioresorbable scaffold for breast reconstruction after cancer approaches market

Milan, Italy – August 5, 2025 – Tensive S.r.l, a clinical-stage advanced biomaterials medical device company, and the developer of REGENERA™ and SOFTAG™ bioresorbable scaffolds for breast reconstruction and tissue marking, has appointed Bill Hunter, MD, as Chairman of its Board of Directors. Dr. Hunter brings more than 30 years of leadership in the medical technology and life sciences sectors. His appointment reflects Tensive’s focus on strengthening its governance and expanding its global network as it accelerates toward pivotal clinical milestones and commercialization in the U.S. and Europe.

Tallinna Vesi’s second-quarter sales reached €19.4 million

AS Tallinna Vesi’s sales in the second quarter were €19.4 million, the increase was mainly driven by the sales of construction services. 

Game On! Tencent Cloud’s EdgeOne Hackathon Is Here

Nearly US$20,000 Prize Pool and 100 Exclusive Rewards for Top Developers Participants use Tencent Cloud EdgeOne to develop games; finalists to showdown for a 24-hour hackathon...

Australian Life Sciences Venture Capital firm Brandon Capital announces Fund Six final close totalling over A$439m

MELBOURNE, Australia, July 24, 2025 (GLOBE NEWSWIRE) -- Brandon Capital, Australasia’s leading life sciences venture capital firm, today announced the final close of its sixth fund at A$439 million.

TELA Bio to Participate in the Canaccord Genuity 45th Annual Growth Conference

MALVERN, Pa., July 23, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will participate in the Canaccord Genuity 45th Annual Growth Conference.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsReconstruction

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers